Gremlich S, Porret A, Hani E H, Cherif D, Vionnet N, Froguel P, Thorens B
Institute of Pharmacology and Toxicology, University of Lausanne, Switzerland.
Diabetes. 1995 Oct;44(10):1202-8. doi: 10.2337/diab.44.10.1202.
Glucose-dependent insulinotropic polypeptide (GIP) is a hormone secreted by the endocrine K-cells from the duodenum that stimulates glucose-induced insulin secretion. Here, we present the molecular characterization of the human pancreatic islet GIP receptor. cDNA clones for the GIP receptor were isolated from a human pancreatic islet cDNA library. They encoded two different forms of the receptor, which differed by a 27-amino acid insertion in the COOH-terminal cytoplasmic tail. The receptor protein sequence was 81% identical to that of the rat GIP receptor. When expressed in Chinese hamster lung fibroblasts, both forms of the receptor displayed high-affinity binding for GIP (180 and 600 pmol/l). GIP binding was displaced by < 20% by 1 mumol/l glucagon, glucagon-like peptide (GLP-I)(7-36) amide, vasoactive intestinal peptide, and secretin. However exendin-4 and exendin-(9-39) at 1 mumol/l displaced binding by approximately 70 and approximately 100% at 10 mumol/l. GIP binding to both forms of the receptor induced a dose-dependent increase in intracellular cAMP levels (EC50 values of 0.6-0.8 nmol/l) but no elevation of cytoplasmic calcium concentrations. Interestingly, both exendin-4 and exendin-(9-39) were antagonists of the receptor, inhibiting GIP-induced cAMP formation by up to 60% when present at a concentration of 10 mumol/l. Finally, the physical and genetic chromosomal localization of the receptor gene was determined to be on 19q13.3, close to the ApoC2 gene. These data will help study the physiology and pathophysiology of the human GIP receptor.
葡萄糖依赖性促胰岛素多肽(GIP)是一种由十二指肠内分泌K细胞分泌的激素,可刺激葡萄糖诱导的胰岛素分泌。在此,我们展示了人胰岛GIP受体的分子特征。从人胰岛cDNA文库中分离出GIP受体的cDNA克隆。它们编码两种不同形式的受体,这两种受体在COOH末端细胞质尾巴上相差27个氨基酸的插入。受体蛋白序列与大鼠GIP受体的序列有81%的同一性。当在中国仓鼠肺成纤维细胞中表达时,两种形式的受体对GIP均显示出高亲和力结合(180和600 pmol/l)。1 μmol/l的胰高血糖素、胰高血糖素样肽(GLP-I)(7-36)酰胺、血管活性肠肽和促胰液素使GIP结合减少<20%。然而,1 μmol/l的艾塞那肽-4和10 μmol/l的艾塞那肽-(9-39)分别使结合减少约70%和约100%。GIP与两种形式的受体结合均诱导细胞内cAMP水平呈剂量依赖性增加(EC50值为0.6-0.8 nmol/l),但细胞质钙浓度没有升高。有趣的是,艾塞那肽-4和艾塞那肽-(9-39)都是该受体的拮抗剂,当浓度为10 μmol/l时,它们可抑制GIP诱导的cAMP形成达60%。最后,确定该受体基因的物理和遗传染色体定位在19q13.3,靠近载脂蛋白C2基因。这些数据将有助于研究人GIP受体的生理学和病理生理学。